Posted on 08/16/2021 11:26:48 AM PDT by NoLibZone
An inexpensive anti-depressant curbed the number of COVID-19 patients ending up in hospital by 30 per cent, making it a potential breakthrough treatment for a virus that continues to spread widely, a Canadian-led clinical trial is reporting.
If confirmed by more research, the drug, fluvoxamine, would be one of the most effective and convenient to treat the virus outside of pricey new “monoclonal antibodies.” They typically have to be administered in a hospital, as opposed to a pill taken orally at home.
Fluvoxamine is given early in the course of the disease, potentially staving off more severe outcomes and their cost to the health-care system.
The relatively large, randomized controlled study was carried out in Brazil and spearheaded by co-principal investigator Ed Mills and other researchers associated with McMaster University in Ontario. It was part of their larger Together trial that is testing a number of potential drug treatments against COVID.
(Excerpt) Read more at nationalpost.com ...
So if we all take anti-depressents prophylactically, we’ll stop complaining about the tyrannical abuses of our government veiled under the umbrella ‘Covid’? We won’t object as they continue to deny us FDA approved drugs that work (Ivermectin, HCQ/AZ). We’ll be nice’n quiet?
Big Pharma can’t male $4B quarterly profits in cheap solutions.
What is soma in Brave New World by Aldous Huxley? In the context of the novel, soma is a recreational drug that several of the main characters take throughout the story. The government in Brave New World strongly encourages individuals to take soma as a way to increase the happiness and complacency of the population. Soma can be taken as a pill or as a powder and can also be released as an aerosol. It is freely available to everyone in the novel. Its inclusion in the text is central to the novel's themes of complacency and resistance in society as well as the theme of escapism.
The words “inexpensive” and “treatment” are what make this a non-starter. There can be no treatment. Only vaccines and masks are allowed.
Evidence for this is mounting steadily. The UK RECOVERY trial shows the weakest effect so far, with a 29% reduction in deaths vs. control.
Probably better with early treatment, and in combination.
The monoclonals are far better, but if they are not available, early treatment with this in combination with IVM is a good plan B. Better than going home and taking aspirin until your O2 sat is 89%, anyway.
Inexpensive = no profits ...it will be banned.
you know I’ve seen several different things being debated as being effective. What I have yet to see is anyone singing the praises of Remdesivir. Although it may help some it certainly is not miracle.
Then again, some who took aspirin recovered, some who ate a hearty plate of lasagna recovered, some who enjoyed a few Reese's peanut butter cups recovered ... And some who took nothing at all and never even felt it recovered.
It's a virus with a 99.7-percent-plus recovery rate.
And then when your covid is gone/cured, do you stop the meds and kill yourself?...
But the study found that 77 of the 739 subjects who were randomly selected to receive fluvoxamine ended up spending more than six hours in an emergency department or being admitted to hospital, compared to 108 of the 733 who were administered a placebo.
...costing only about $4 for a 10-day prescription.
Fluvoxamine does not attack the SARS-CoV-2 virus itself, but addresses that immune response.
April 2021: There is insufficient evidence for the COVID-19 Treatment Guidelines Panel to recommend either for or against the use of fluvoxamine for the treatment of COVID-19. Results from adequately powered, well-designed, and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of fluvoxamine for the treatment of COVID-19.
NIH examined two clinical trials:
1. Placebo-Controlled Randomized Trial in Nonhospitalized Adults With Mild COVID-19
• None of 80 participants (0%) who received fluvoxamine and six of 72 participants (8.3%) who received placebo reached the primary endpoint (absolute difference 8.7%; 95% CI, 1.8% to 16.5%; P = 0.009).
• Five participants in the placebo arm and one in the fluvoxamine arm required hospitalization.
2. Prospective Observational Study During an Outbreak of SARS-CoV-2 Infections
• At Day 14, none of the patients who received fluvoxamine versus 60% of those who did not had persistent symptoms (e.g., anxiety, difficulty concentrating, fatigue) (P < 0.001).
• By Day 14, none of the fluvoxamine-treated patients were hospitalized; six patients who did not receive fluvoxamine were hospitalized, including two patients who required care in the intensive care unit.
• No serious adverse events were reported following receipt of fluvoxamine.
Isn’t that the one Brett Weinstein has been talking about?
Fluvoxamine is not FDA-approved for the treatment of any infection.
https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/fluvoxamine/
No thanks.
I thought this was about Prozac but that’s fluoxetine. Cross your eyes and fluvoxamine looks pretty much the same.
Is it an SSRI?
Remdesivir totally sucks.
Don’t forget some who drank champagne daily at Happy Hour recovered.
And just because you’ve recovered, you can still use it for prophylaxis treatment.
Such a multi-faceted libation!
Is this related to fluoxetine (Prozac)?
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.